In-Vitro Diagnostics Market Analysis by Product Type, Technology, Application, End-Users (2020 – 2025)
In-Vitro Diagnostics Market Analysis by Product Type, Technology, Application, End-Users (2020 – 2025)
The In-Vitro Diagnostics study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global in-vitro diagnostics market generated revenue of US$ XX.X million in 2020 and is expected to reach US$ XX.X million by 2025 with a CAGR of XX.X% in the forecast period. The study offers a detailed analysis of the global market for in-vitro diagnostics. Considering 2019 as the base year, the report provides market information for the 2020 to 2025 forecast period. The study includes information on the current size and projected growth of the overall in-vitro diagnostics market and its associated business segments. It outlines the dynamics, the business environment, and emerging developments in the in-vitro diagnostics market.
The study contains a chapter that explains the impact of COVID 19 on the in-vitro diagnostics market. The study further discusses the key factors, the business environment, and emerging developments in the in-vitro diagnostics market. The report will help several vendors to make the right investment and development decisions. The research focuses on the in-vitro diagnostics scenario and its proliferation across various market verticals. The descriptions in this report cover factors that currently influence and impede market growth and also accelerate the future dimensions of demand for the in-vitro diagnostics market.
The chapters included in the report describe leading players in the in-vitro diagnostics market. The study provides landscape analysis, which offers detailed profiles of major players in the in-vitro diagnostics market worldwide. The report covers a fine-grained taxonomy of market segmentation in terms of product type, technology, application, end-users, and region.
Global In-Vitro Diagnostics Market, by Product Type
o Instruments (Fully Automated Instruments, Semi Automated Instruments, Others)
o Reagent & Kits
o Data Management Software
o Services
Global In-Vitro Diagnostics Market, By Technology
o Clinical Chemistry
o Coagulation & Hemostasis
o Hematology
o Immunochemistry/Immunoassay
o Microbiology
o Molecular Diagnostics
o Urinalysis
o Others
Global In-Vitro Diagnostics Market, By Application
o Autoimmune Diseases
o Diabetes
o Drug Testing/ Pharmacogenomics
o HIV/ AIDS
o Infectious Diseases
o Nephrology
o Oncology/Cancer
o Others
Global In-Vitro Diagnostics Market, By End-Users
o Academics
o Hospitals
o Laboratories
o Patient-Self-Testing
o Point-of-Care- Testing
o Others
Global In-Vitro Diagnostics Market, By Region
o North America (U.S. Canada)
o Europe (Germany, U.K., France, Italy, Spain, Rest of Europe)
o Asia Pacific (China, Japan, India, Rest of Asia Pacific)
o Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa)
o Latin America (Brazil, Mexico, Rest of Latin America)
Market Players
Some of the major players in the in-vitro diagnostics market are as follows:
o Roche Diagnostics Limited
o Siemens
o Danaher Corporation
o Abbott Laboratories
o Thermo Laboratories
o Johnson & Johnson
o Becton, Dickinson and Company
o Bio-Rad Laboratories
o SysmexCorporation
o bioMeriexus
1. Introduction
2. Market Overview
2.1. Global In-Vitro Diagnostics Market Introduction
2.2. Macro- Economic Factor
2.3. Market Determinants
2.3.1. Market Driver
2.3.2. Market Restraints
2.3.3. Market Opportunities
2.3.4. Market Challenges
2.4. Technology/Product Roadmap
2.5. PEST Analysis
2.6. Market Growth Opportunity Analysis
3. Market Segmentation
3.1. Global In-Vitro Diagnostics Market Analysis (US$ Mn), By Product Type, 2019 – 2025
3.1.1. Instruments
3.1.1.1. Fully Automated Instruments
3.1.1.2. Semi Automated Instruments
3.1.1.3. Others
3.1.2. Reagent & Kits
3.1.3. Data Management Software
3.1.4. Services
3.2. Global In-Vitro Diagnostics Market Analysis (US$ Mn), By Technology, 2019 - 2025
3.2.1. Clinical Chemistry
3.2.2. Coagulation & Hemostasis
3.2.3. Hematology
3.2.4. Immunochemistry/Immunoassay
3.2.5. Microbiology
3.2.6. Molecular Diagnostics
3.2.7. Urinalysis
3.2.8. Others
3.3. Global In-Vitro Diagnostics Market Analysis (US$ Mn), By Application, 2019 – 2025
3.3.1. Autoimmune Diseases
3.3.2. Diabetes
3.3.3. Drug Testing/ Pharmacogenomics
3.3.4. HIV/ AIDS
3.3.5. Infectious Diseases
3.3.6. Nephrology
3.3.7. Oncology/Cancer
3.3.8. Others
3.4. Global In-Vitro Diagnostics Market Analysis (US$ Mn), By End-Users, 2019 – 2025
3.4.1. Academics
3.4.2. Hospitals
3.4.3. Laboratories
3.4.4. Patient-Self-Testing
3.4.5. Point-of-Care- Testing
3.4.6. Others
4. Regional Analysis
4.1. North America In-Vitro Diagnostics Market Analysis (US$ Mn), 2019 - 2025
4.1.1. By Country
4.1.1.1. U.S.
4.1.1.2. Canada
4.1.2. By Product Type
4.1.2.1. Instruments
4.1.2.1.1. Fully-automated Instruments
4.1.2.1.2. Semi-automated Instruments
4.1.2.1.3. Others
4.1.2.2. Reagents & Kits
4.1.2.3. Data Management Software
4.1.2.4. Services
4.1.3. By Technology
4.1.3.1. Clinical Chemistry
4.1.3.2. Coagulation & Hemostasis
4.1.3.3. Hematology
4.1.3.4. Immunochemistry/Immunoassay
4.1.3.5. Microbiology
4.1.3.6. Molecular Diagnostics
4.1.3.7. Urinalysis
4.1.3.8. Others
4.1.4. By Application
4.1.4.1. Autoimmune Diseases
4.1.4.2. Diabetes
4.1.4.3. Drug Testing/ Pharmacogenomics
4.1.4.4. HIV/ AIDS
4.1.4.5. Infectious Diseases
4.1.4.6. Nephrology
4.1.4.7. Oncology/Cancer
4.1.4.8. Others
4.1.5. By End-Users
4.1.5.1. Academics
4.1.5.2. Hospitals
4.1.5.3. Laboratories
4.1.5.4. Patient-Self-Testing
4.1.5.5. Point-of-Care- Testing
4.1.5.6. Others
4.2. Europe In-Vitro Diagnostics Market Analysis (US$ Mn), 2019 - 2025
4.2.1. By Country, 2019 – 2025
4.2.1.1. Germany
4.2.1.2. U.K.
4.2.1.3. France
4.2.1.4. Italy
4.2.1.5. Spain
4.2.1.6. Rest of Europe
4.2.2. By Product Type
4.2.2.1. Instruments
4.2.2.1.1. Fully-automated Instruments
4.2.2.1.2. Semi-automated Instruments
4.2.2.1.3. Others
4.2.2.2. Reagents & Kits
4.2.2.3. Data Management Software
4.2.2.4. Services
4.2.3. By Technology
4.2.3.1. Clinical Chemistry
4.2.3.2. Coagulation & Hemostasis
4.2.3.3. Hematology
4.2.3.4. Immunochemistry/Immunoassay
4.2.3.5. Microbiology
4.2.3.6. Molecular Diagnostics
4.2.3.7. Urinalysis
4.2.3.8. Others
4.2.4. By Application
4.2.4.1. Autoimmune Diseases
4.2.4.2. Diabetes
4.2.4.3. Drug Testing/ Pharmacogenomics
4.2.4.4. HIV/ AIDS
4.2.4.5. Infectious Diseases
4.2.4.6. Nephrology
4.2.4.7. Oncology/Cancer
4.2.4.8. Others
4.2.5. By End-Users
4.2.5.1. Academics
4.2.5.2. Hospitals
4.2.5.3. Laboratories
4.2.5.4. Patient-Self-Testing
4.2.5.5. Point-of-Care- Testing
4.2.5.6. Others
4.3. Asia Pacific In-Vitro Diagnostics Market Analysis (US$ Mn), 2019 - 2025
4.3.1. By Country, 2019 – 2025
4.3.1.1. China
4.3.1.2. Japan
4.3.1.3. India
4.3.1.4. Rest of Asia Pacific
4.3.2. By Product Type
4.3.2.1. Instruments
4.3.2.1.1. Fully-automated Instruments
4.3.2.1.2. Semi-automated Instruments
4.3.2.1.3. Others
4.3.2.2. Reagents & Kits
4.3.2.3. Data Management Software
4.3.2.4. Services
4.3.3. By Technology
4.3.3.1. Clinical Chemistry
4.3.3.2. Coagulation & Hemostasis
4.3.3.3. Hematology
4.3.3.4. Immunochemistry/Immunoassay
4.3.3.5. Microbiology
4.3.3.6. Molecular Diagnostics
4.3.3.7. Urinalysis
4.3.3.8. Others
4.3.4. By Application
4.3.4.1. Autoimmune Diseases
4.3.4.2. Diabetes
4.3.4.3. Drug Testing/ Pharmacogenomics
4.3.4.4. HIV/ AIDS
4.3.4.5. Infectious Diseases
4.3.4.6. Nephrology
4.3.4.7. Oncology/Cancer
4.3.4.8. Others
4.3.5. By End-Users
4.3.5.1. Academics
4.3.5.2. Hospitals
4.3.5.3. Laboratories
4.3.5.4. Patient-Self-Testing
4.3.5.5. Point-of-Care- Testing
4.3.5.6. Others
4.4. Middle East & Africa In-Vitro Diagnostics Market Analysis (US$ Mn), 2019 - 2025
4.4.1. By Country, 2019 – 2025
4.4.1.1. GCC
4.4.1.2. South Africa
4.4.1.3. Rest of Middle East & Africa
4.4.2. By Product Type
4.4.2.1. Instruments
4.4.2.1.1. Fully-automated Instruments
4.4.2.1.2. Semi-automated Instruments
4.4.2.1.3. Others
4.4.2.2. Reagents & Kits
4.4.2.3. Data Management Software
4.4.2.4. Services
4.4.3. By Technology
4.4.3.1. Clinical Chemistry
4.4.3.2. Coagulation & Hemostasis
4.4.3.3. Hematology
4.4.3.4. Immunochemistry/Immunoassay
4.4.3.5. Microbiology
4.4.3.6. Molecular Diagnostics
4.4.3.7. Urinalysis
4.4.3.8. Others
4.4.4. By Application
4.4.4.1. Autoimmune Diseases
4.4.4.2. Diabetes
4.4.4.3. Drug Testing/ Pharmacogenomics
4.4.4.4. HIV/ AIDS
4.4.4.5. Infectious Diseases
4.4.4.6. Nephrology
4.4.4.7. Oncology/Cancer
4.4.4.8. Others
4.4.5. By End-Users
4.4.5.1. Academics
4.4.5.2. Hospitals
4.4.5.3. Laboratories
4.4.5.4. Patient-Self-Testing
4.4.5.5. Point-of-Care- Testing
4.4.5.6. Others
4.5. Latin America In-Vitro Diagnostics Market Analysis (US$ Mn), 2019 - 2025
4.5.1. By Country, 2019 – 2025
4.5.1.1. Brazil
4.5.1.2. Mexico
4.5.1.3. Rest of Latin America
4.5.2. By Product Type
4.5.2.1. Instruments
4.5.2.1.1. Fully-automated Instruments
4.5.2.1.2. Semi-automated Instruments
4.5.2.1.3. Others
4.5.2.2. Reagents & Kits
4.5.2.3. Data Management Software
4.5.2.4. Services
4.5.3. By Technology
4.5.3.1. Clinical Chemistry
4.5.3.2. Coagulation & Hemostasis
4.5.3.3. Hematology
4.5.3.4. Immunochemistry/Immunoassay
4.5.3.5. Microbiology
4.5.3.6. Molecular Diagnostics
4.5.3.7. Urinalysis
4.5.3.8. Others
4.5.4. By Application
4.5.4.1. Autoimmune Diseases
4.5.4.2. Diabetes
4.5.4.3. Drug Testing/ Pharmacogenomics
4.5.4.4. HIV/ AIDS
4.5.4.5. Infectious Diseases
4.5.4.6. Nephrology
4.5.4.7. Oncology/Cancer
4.5.4.8. Others
4.5.5. By End-Users
4.5.5.1. Academics
4.5.5.2. Hospitals
4.5.5.3. Laboratories
4.5.5.4. Patient-Self-Testing
4.5.5.5. Point-of-Care- Testing
4.5.5.6. Others
5. Competitive Analysis
5.1. Company Share Analysis (%) 2019
5.2. List of Acquisition, Merger, Collaboration & New Product Launch
6. Company Profiles
6.1. Roche Diagnostics Limited
6.2. Siemens
6.3. Danaher Corporation
6.4. Abbott Laboratories
6.5. Thermo Laboratories
6.6. Johnson & Johnson
6.7. Becton, Dickinson and Company
6.8. Bio-Rad Laboratories
6.9. Sysmex Corporation
6.10. bioMeriexus
Research Methodology:
In-Vitro Diagnostics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|